Genentech nears trade secrets suit settlement with Taiwanese company but still targeting former employees


Biotech powerhouse Genentech Inc. is close to settling a with a Taiwanese company that allegedly stole trade secrets and planned to launch a look-alike version of one of Genentech's most popular drugs.

The settlement between the South San Francisco-based U.S. unit of drug giant Roche and JHL Biotech Inc. requires the Taiwanese company to stop development of biosimilar versions of Genentech's cancer drugs Rituxan, Herceptin and Avastin — all multibillion-dollar biologics — and the cystic fibrosis…

Previous Report: Vista Equity raises record-breaking $16B fund
Next Mallinckrodt to settle two opioid suits for $24M

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *